• 제목/요약/키워드: PBPK

검색결과 21건 처리시간 0.035초

Prediction of Pharmacokinetics and Penetration of Moxifloxacin in Human with Intra-Abdominal Infection Based on Extrapolated PBPK Model

  • Zhu, LiQin;Yang, JianWei;Zhang, Yuan;Wang, YongMing;Zhang, JianLei;Zhao, YuanYuan;Dong, WeiLin
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제19권2호
    • /
    • pp.99-104
    • /
    • 2015
  • The aim of this study is to develop a physiologically based pharmacokinetic (PBPK) model in intra-abdominal infected rats, and extrapolate it to human to predict moxifloxacin pharmacokinetics profiles in various tissues in intra-abdominal infected human. 12 male rats with intra- abdominal infections, induced by Escherichia coli, received a single dose of 40 mg/kg body weight of moxifloxacin. Blood plasma was collected at 5, 10, 20, 30, 60, 120, 240, 480, 1440 min after drug injection. A PBPK model was developed in rats and extrapolated to human using GastroPlus software. The predictions were assessed by comparing predictions and observations. In the plasma concentration versus time profile of moxifloxcinin rats, $C_{max}$ was $11.151{\mu}g/mL$ at 5 min after the intravenous injection and $t_{1/2}$ was 2.936 h. Plasma concentration and kinetics in human were predicted and compared with observed datas. Moxifloxacin penetrated and accumulated with high concentrations in redmarrow, lung, skin, heart, liver, kidney, spleen, muscle tissues in human with intra-abdominal infection. The predicted tissue to plasma concentration ratios in abdominal viscera were between 1.1 and 2.2. When rat plasma concentrations were known, extrapolation of a PBPK model was a method to predict drug pharmacokinetics and penetration in human. Moxifloxacin has a good penetration into liver, kidney, spleen, as well as other tissues in intra-abdominal infected human. Close monitoring are necessary when using moxifloxacin due to its high concentration distribution. This pathological model extrapolation may provide reference to the PK/PD study of antibacterial agents.

Extrapolation of Hepatic Concentrations of Industrial Chemicals Using Pharmacokinetic Models to Predict Hepatotoxicity

  • Yamazaki, Hiroshi;Kamiya, Yusuke
    • Toxicological Research
    • /
    • 제35권4호
    • /
    • pp.295-301
    • /
    • 2019
  • In this review, we describe the absorption rates (Caco-2 cell permeability) and hepatic/plasma pharmacokinetics of 53 diverse chemicals estimated by modeling virtual oral administration in rats. To ensure that a broad range of chemical structures is present among the selected substances, the properties described by 196 chemical descriptors in a chemoinformatics tool were calculated for 50,000 randomly selected molecules in the original chemical space. To allow visualization, the resulting chemical space was projected onto a two-dimensional plane using generative topographic mapping. The calculated absorbance rates of the chemicals based on cell permeability studies were found to be inversely correlated to the no-observed-effect levels for hepatoxicity after oral administration, as obtained from the Hazard Evaluation Support System Integrated Platform in Japan (r = -0.88, p < 0.01, n = 27). The maximum plasma concentrations and the areas under the concentration-time curves (AUC) of a varied selection of chemicals were estimated using two different methods: simple one-compartment models (i.e., high-throughput toxicokinetic models) and simplified physiologically based pharmacokinetic (PBPK) modeling consisting of chemical receptor (gut), metabolizing (liver), and central (main) compartments. The results obtained from the two methods were consistent. Although the maximum concentrations and AUC values of the 53 chemicals roughly correlated in the liver and plasma, inconsistencies were apparent between empirically measured concentrations and the PBPK-modeled levels. The lowest-observed-effect levels and the virtual hepatic AUC values obtained using PBPK models were inversely correlated (r = -0.78, p < 0.05, n = 7). The present simplified PBPK models could estimate the relationships between hepatic/plasma concentrations and oral doses of general chemicals using both forward and reverse dosimetry. These methods are therefore valuable for estimating hepatotoxicity.

A Physiologically Based Pharmacokinetic Model for Absorption and Distribution of Imatinib in Human Body

  • Chowdhury, Mohammad Mahfuz;Kim, Do-Hyun;Ahn, Jeong-Keun
    • Bulletin of the Korean Chemical Society
    • /
    • 제32권11호
    • /
    • pp.3967-3972
    • /
    • 2011
  • A whole body physiologically based pharmacokinetic (PBPK) model was applied to investigate absorption, distribution, and physiologic variations on pharmacokinetics of imatinib in human body. Previously published pharmacokinetic data of the drug after intravenous (i.v.) infusion and oral administration were simulated by the PBPK model. Oral dose absorption kinetics were analyzed by adopting a compartmental absorption and transit model in gut section. Tissue/plasma partition coefficients of drug after i.v. infusion were also used for oral administration. Sensitivity analysis of the PBPK model was carried out by taking parameters that were commonly subject to variation in human. Drug concentration in adipose tissue was found to be higher than those in other tissues, suggesting that adipose tissue plays a role as a storage tissue for the drug. Variations of metabolism in liver, body weight, and blood/plasma partition coefficient were found to be important factors affecting the plasma concentration profile of drug in human body.

지하수로부터 방출된 라돈에 의한 현실적인 체내축적량 평가 (A Realistic Human Exposure Assessment of Indoor Radon released from Groundwater)

  • 유동한;한문희
    • Journal of Radiation Protection and Research
    • /
    • 제27권2호
    • /
    • pp.121-126
    • /
    • 2002
  • 본 연구는 지하수로부터 방출되어 가옥의 실내에 존재하는 라돈에 의한 체내축적량을 현실적으로 평가하는 방법을 보여준다. 먼저 지하수로부터 실내공기로 전달되는 과정을 모의하기 위해 2_구역모델을 개발하였다. 이 모델은 실내에서 발생하는 생활활동, 즉, 목욕, 세수, 세탁, 변기에서의 물사용에 의해 실내로 휘발, 이동하는 시간에 따를 라돈농도분포를 계산한다. 다음, 이 모델의 불확실성이 존재하는 입력인자들에 대해 불확실성분석을 수행하여 최종 실내라돈 농도분포를 결정하였다. 그리고 이러한 실내 라돈을 호흡하여 체내에 축적되는 양을 보다 정량적으로 모의하기 위해 PBPK 모델을 개발하였다. 불확실성이 포함된 라돈농도분포와 정량적인 체내축적모의를 위한 PBPK 모델의 결합으로 보다 현실적인 라돈의 체내축적량을 분석할 수 있다. 이러한 연구의 결과는 지하수로부터 발생하는 라돈에 의한 인체위해평가시 도움을 주리라고 판단된다.

Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans

  • Bae, Soo Hyeon;Park, Wan-Su;Han, Seunghoon;Park, Gab-jin;Lee, Jongtae;Hong, Taegon;Jeon, Sangil;Yim, Dong-Seok
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제22권3호
    • /
    • pp.321-329
    • /
    • 2018
  • It was recently reported that the $C_{max}$ and AUC of rosuvastatin increases when it is coadministered with telmisartan and cyclosporine. Rosuvastatin is known to be a substrate of OATP1B1, OATP1B3, NTCP, and BCRP transporters. The aim of this study was to explore the mechanism of the interactions between rosuvastatin and two perpetrators, telmisartan and cyclosporine. Published (cyclosporine) or newly developed (telmisartan) PBPK models were used to this end. The rosuvastatin model in Simcyp (version 15)'s drug library was modified to reflect racial differences in rosuvastatin exposure. In the telmisartan-rosuvastatin case, simulated rosuvastatin $C_{maxI}/C_{max}$ and $AUC_I/AUC$ (with/without telmisartan) ratios were 1.92 and 1.14, respectively, and the $T_{max}$ changed from 3.35 h to 1.40 h with coadministration of telmisartan, which were consistent with the aforementioned report ($C_{maxI}/C_{max}$: 2.01, $AUC_I/AUC$:1.18, $T_{max}:5h{\rightarrow}0.75h$). In the next case of cyclosporine-rosuvastatin, the simulated rosuvastatin $C_{maxI}/C_{max}$ and $AUC_I/AUC$ (with/without cyclosporine) ratios were 3.29 and 1.30, respectively. The decrease in the $CL_{int,BCRP,intestine}$ of rosuvastatin by telmisartan and cyclosporine in the PBPK model was pivotal to reproducing this finding in Simcyp. Our PBPK model demonstrated that the major causes of increase in rosuvastatin exposure are mediated by intestinal BCRP (rosuvastatin-telmisartan interaction) or by both of BCRP and OATP1B1/3 (rosuvastatin-cyclosporine interaction).

지하수에서 유래한 벤젠의 노출경로별 인체축적특성 (Accumulation Property in Human Body of Benzene Derived from Groundwater According to Exposure Pathway)

  • 김상준;이현호;박지연;이유진;유동한;양지원
    • 한국지하수토양환경학회지:지하수토양환경
    • /
    • 제9권1호
    • /
    • pp.12-27
    • /
    • 2004
  • 본 연구에서는 벤젠을 대상으로 오염된 지하수를 생활용수로 사용했을 때 발생하는 실내오염도를 모사하고 실내에서 가능한 흡입, 섭취, 피부흡수와 같은 노출경로를 고려하여 노출시나리오를 자성하였다. 인체에 유입된 벤젠에 대하여 PBPK 모델을 이용하여 인체의 각 장기에 어떻게 분포하는지를 분석하였다. 결과에서 흡입과 섭취가 주요노출 경로였으며 남성이 여성보다 많은 호흡량으로 인해 보다 높은 노출속도를 유지하였다. 노출속도에 대한 피부흡수의 공헌도는 상대적으로 매우 작았다. 단기노출의 결과 오염물 노출에 대하여 SPT, RPT,간의 정맥혈 중 벤젠농도는 빠르게 증감하는 반면 지방의 경우는 느리게 반응하였고 많은 벤젠이 지방세포에 축적되어 정맥혈에는 적은 농도로 존재하였다. 장기간 노출에서 여성은 남성보다 전체적으로 2.1배 많은 벤젠을 체내에 축적하고 있는 것으로 나타났다. 장기간 노출에서 총유입벤젠의 98%가 호흡과 대사분해에 의해 제거되었다. 흡입경로는 벤젠이 호흡배출에 의해 69.8% 제거되었으며 섭취경로는 48.4%로 오염물이 유입되는 위치에 따라 각각의 제거기작의 공헌도가 다르게 나타났다. 본 연구의 결과는 실내오염에 따라 오염물이 체내에 흡수되고 분포ㆍ제거되는 현상을 이해하고 노출저감대책을 마련하는데 필요한 자료를 제공하고자 하였다.

지하수로 인한 실내라돈오염시 현실적인 인체노출량 평가 (Realistic Internal Dose Assessment of Indoor Radon Pollution by Groundwater)

  • 유동한;이한수
    • 한국대기환경학회:학술대회논문집
    • /
    • 한국대기환경학회 2002년도 춘계학술대회 논문집
    • /
    • pp.117-118
    • /
    • 2002
  • 본 연구에서는 지하수로부터 방출된 실내라돈오염을 해석하기 위한 수학적 모델에서 모델인자들의 불확실성을 고려하고 인체축적량을 정량적으로 해석하는 PBPK모델을 사용하여 호흡을 통한 라돈의 인체축적량을 보다 현실적으로 평가하려고 한다. 우선, 전에 사용한 3 구역모델을 샤워실과 화장실을 구분하는 경계가 없다는 국내실정을 감안하여 보다 현실적으로 개량한 2-구역 모델을 개발하였다. (중략)

  • PDF

혼합물에서 화학물질간의 상호작용 효과 (Interaction effect of Chemical Mixtures)

  • 임종환;신주연;김용규
    • 대한임상독성학회지
    • /
    • 제3권1호
    • /
    • pp.11-16
    • /
    • 2005
  • Chemical mixtures of components, each of which are present at less than guidance concentrations, may be hazardous due to additivity, interactions, or both. Toxicological interactions may increase the health hazard above what would be expected from an assessment of each component singly, or all components additively. So chemical mixture are a particular issue in public health. There are several approach to assess whether there are additivity or interaction in assessing toxicological effects, such as, components-based approach, physiologically-based pharmacokinetic /pharmacodynamic(PBPK/PD) models, hazard index method, and weight-of evidence method. If we consider interaction or additivity effects in assessing the health effects of chemcial mixtures, we can get more accurate information about toxicological effects and dose-response relationship in chemical mixtures.

  • PDF

Physiologically Based Pharmacokinetic (PBPK) Modeling in Neurotoxicology

  • Kim, Chung-Sim
    • 한국응용약물학회:학술대회논문집
    • /
    • 한국응용약물학회 1995년도 제3회 추계심포지움
    • /
    • pp.135-136
    • /
    • 1995
  • Resent advances in computer technology have introduced a sophisticated capability for computing the biological fate of toxicants in a biological system. This methodology, which has drastically altered risk assessment skill in toxicology, is designed using all the mechanistic information, and all claim better accuracy with extrapolating capability Iron animal to people than conventional pharmacokinetic methods. Biologically based mathematical models in which the specific mechanistic steps governing tissue disposition(pharmacokinetics) and toxic action (pharmacodynamics) of chemicals are constructed in quantitative terms by a set of equations loading to prediction of the outcome of specific toxicological experiments by computer simulation. pharmacokinetic and pharmacodynamic models are useful in risk assessment because their mechanistic biological basis permits the high-to-low dose, route to route and interspecies extrapolation of the tissue disposition and toxic action of chemicals.

  • PDF